|
Analyses of factors influencing the acute effect of octreotide in growth hormone-secreting adenomas
|
27 September 2013 |
|
Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan
|
26 September 2013 |
|
Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas
|
26 September 2013 |
|
Expression of prolactin and prolactin receptors by non-Hodgkin's lymphoma cells
|
24 September 2013 |
|
The expression of the phosphotyrosine phosphatase DEP-1/PTPeta dictates the responsivity of glioma cells to somatostatin inhibition of cell proliferation
|
24 September 2013 |
|
Vitamin D and its analog EB1089 induce p27 accumulation and diminish association of p27 with Skp2 independent of PTEN in pituitary corticotroph cells
|
23 September 2013 |
|
Comparison of protein expression in two prostate cancer cell-lines, LNCaP and DU145, after treatment with somatostatin
|
23 September 2013 |
|
Efficacy of bromocriptine in the treatment of metastatic breast cancer- and prostate cancer-related hyperprolactinemia
|
20 September 2013 |
|
Somatostatin receptor-1 induces cell cycle arrest and inhibits tumor growth in pancreatic cancer
|
20 September 2013 |
|
Dephosphorylation of cancer protein by tyrosine phosphatases in response to analogs of luteinizing hormone-releasing hormone and somatostatin
|
19 September 2013 |